Fundamental Analysis
GRAB 1D - picking phones off the market floor again?GRAB pulled back exactly into the 4.90–5.10 buy-zone, where the wedge retest aligns with the MA200 - a major technical cluster that previously launched strong impulses. Oscillators show deep oversold conditions, candles print buyer tails, and the first resistance sits at 5.35, matching the 0.618 retracement. A breakout above 5.35 opens the path toward 8.65 (1.618), and a move above 6.80 could initiate a larger rally toward 11.92 based on the 2.618 extension.
Company: Grab Holdings is Southeast Asia’s largest super-app platform, combining ride-hailing, food delivery, fintech, payments, and micro-lending across Singapore, Malaysia, Indonesia, Thailand, and Vietnam.
Fundamentally , as of November 19, GRAB continues to strengthen: gross profit and GMV grow, operational efficiency improves, and both ride-hailing and delivery segments have reached sustainable profitability. Fintech is expanding at double-digit rates, margins improve as subsidies are reduced, and operating losses continue to shrink. Cash flow strengthens, the path to full profitability is visible, and the overall digital-services boom across Southeast Asia remains a long-term driver for growth. Competition cooled, monetization improved - exactly то environment the company needed.
Technically , the bullish scenario holds as long as price stays above 4.90–5.10. A breakout above 5.35 activates the 8.65 target, and the major upside - 11.92 - becomes realistic once price gets above 6.80. A drop below 4.80 complicates the picture, but current structure still looks like a controlled reset rather than a trend break.
Grab acting like usual: discounts first, acceleration later - Southeast Asia likes this script.
Breakout in progress
GALT is starting a breakout after reporting good news at the AASLD liver conference for the #1 untapped market for big pharma, liver cirrhosis.
There is prior industry precedent that a buyout could send the stock price into the triple digits.
Why GALT’s Fibrosis Data Are Better Than Any Other MASH Company
1. They are showing fibrosis improvement in true compensated cirrhosis (F4) — the population where EVERY OTHER DRUG HAS FAILED.
Almost all other “great” fibrosis results in MASH come from F2–F3 populations (Akero, 89bio, Madrigal).
Fibrosis moves easily there. But in biopsy-confirmed F4 cirrhosis with portal hypertension, fibrosis essentially does not reverse in modern trials.
This is why Gilead, Intercept, NGM, Novartis, Genfit, and Madrigal all failed in this population.
GALT is the first to repeatedly show biomarker improvement AND fewer clinical events in compensated cirrhosis.
No other company has done that.
2. The magnitude of fibrosis-biomarker improvement is unusually large and consistent across ALL major antifibrotic markers.
At 18 months (NAVIGATE):
• Pro-C3 reduction: >50% vs baseline
This is the main “fibrogenesis” marker.
Competitors usually get ~20–30% reduction in easier F2–F3 patients.
• ELF score: clinically meaningful drop
Again, competitors rarely get ELF improvement in cirrhosis.
• FibroScan liver stiffness: improved
Liver stiffness almost always worsens in F4 patients.
Belapectin produced improvement.
• YKL-40 / other collagen markers: improved
Indicates reduced macrophage-driven scarring.
What’s unique:
Other companies may improve one marker (e.g., ALT, MRI-PDFF, or PRO-C3),
but GALT shows simultaneous improvement across the entire fibrosis parameter set in cirrhosis.
That has not been replicated by any other company.
3. Only GALT has shown a link between fibrosis biomarkers → portal pressure improvement → fewer cirrhosis complications.
This is the reason the field is paying attention.
HVPG (portal pressure) improvement
Belapectin produced meaningful drops in HVPG — the FDA’s gold-standard surrogate for preventing variceal bleeding, ascites, transplant, and death.
No other MASH drug has ever shown a consistent HVPG improvement in cirrhosis.
Reduced clinical progression
Belapectin-treated patients developed fewer new esophageal varices, which is the #1 warning sign of impending decompensation.
This matches the HVPG signal.
It matches the biomarkers.
This “full chain” alignment is unmatched:
Fibrosis biomarkers improve
Portal pressure decreases
Varices occur less often
Disease stays compensated
Other companies haven’t shown this chain — not even close.
4. The 36-month follow-up CONFIRMED the benefit keeps going — something almost no MASH drug has ever shown.
At 36 months:
• New varices incidence: 12.4% at 2 mg/kg vs 23.4% placebo
The advantage persisted for 3 years.
This is extremely rare in cirrhosis.
• Biomarker improvements remained stable
PRO-C3, ELF, liver stiffness all stayed improved.
Durability is critical:
Many drugs show an early signal that disappears later.
Belapectin’s signal strengthens with time.
No other MASH drug has shown a 36-month antifibrotic durability signal with matching clinical outcomes.
5. Mechanistically, belapectin is the only drug directly targeting activated macrophage–galectin-3 fibrosis architecture.
Other drugs target:
Fat reduction (Madrigal)
Metabolic pathways (89bio, Akero)
FGF signaling
Lipid metabolism
Inflammation
Those help in F2/F3 — but not in F4.
Belapectin targets the scaffolding of fibrotic architecture itself by inhibiting galectin-3 on activated macrophages.
This mechanism explains why:
• GALT works in cirrhosis but others fail.
• Biomarker improvements line up across every fibrosis marker.
• HVPG drops.
• 36-month clinical progression slows down.
It’s the right mechanism for the right stage of disease.
6. The field desperately needs a drug for compensated cirrhosis — and GALT is alone.
Every other company is fighting over:
F2/F3
Early fibrosis
Resmetirom-like mechanisms
MRI-PDFF reductions
Triglycerides
ALT normalization
Body-weight changes
But none of that matters in F4.
Regulators, hepatologists, and payers want something that:
Slows portal pressure rise
Prevents varices
Delays decompensation
Reduces need for transplant
Only belapectin has shown all of that together.
THE SIMPLE ANSWER
GALT’s fibrosis data are better than any other MASH company because they succeed exactly where every other program has failed: reversing fibrosis biology, lowering portal pressure, and slowing clinical progression in real compensated cirrhosis — with signals that persist out to 36 months and are consistent across all major biomarker categories.
No other company in MASH has shown:
deep PRO-C3 reduction
ELF improvement
liver stiffness improvement
HVPG reduction
fewer varices
36-month durability
in true F4 cirrhosis
with a fibrosis-architecture mechanism
GALT is alone in that category.
BFAGROBUY Call BFAGRO
Trend line breake with volume and bullish news Barkat Frisian Agro Ltd
🚀 Barkat Frisian Agro Ltd (PSX: BFAGRO) – BUY CALL
📣 Bullish Fundamental Update – Fresh Catalyst Alert
Barkat Frisian has officially established its wholly-owned UAE subsidiary in the **Meydan Freezone, Dubai
Because the company is:
Expanding internationally
Increasing exports
Creating a base in UAE (a major business hub)
Seeking higher sales
Strengthening its brand
Enhancing long-term profitability
EUR/USD long: Expect volatility leading up to US NFP dataHello traders
I have closed my EUR/USD short for a 63 pip profit.
I have initiated a long EUR/USD position at 1.1583 with a stop at 1.1560.
The USA NFP data on Thursday is guaranteed to create volatility for the rest of the week.
TECHNICAL:
EUR/USD is holding steady above a weekly close level.
GOLD is also steady above the weekly close of 4000/oz
DXY is below a weekly close and formed a Doji candle yesterday. If tomorrow's close is lower, it will be an evening star pattern.
US Government Bonds 10Y Yield is close to the third touch on a downtrend line
BTC is recovering from matching the 1/1/2025 monthly low at 89,000
FUNDAMENTAL:
Uncertainty rules but there are some bright spots. The Trump administration has rolled back tariffs on food items not produced in the USA. Coffee beans (duuhhhh...) but thanks for your beautiful Kona beans, Hawaii.
Tomatoes(bulk imported from Mexico and Canada)
Bananas... like his tariff spree
The US Supreme Court decision on the legality of the tariffs may land sooner than later.
Most important in my opinion: The election results in an off-year. Barring special elections, the results show that America is pissed off. He promised lower inflation, food and gas prices, the end to the Ukraine/Russia war, release of the Epstein files(probably happening tomorrow but wait for the twist, just like his tax returns that are still under audit by the IRS... LOL.) My bet is that the DOJ will announce that not all files can be released due to an ongoing investigation into, yes, Democrats.
All these broken promises and chaos must weigh on international investors decisions on the continued sensibility of investing in the USA.
Longer term I am not too concerned about that theme but it remains to be seen what the totality of the damage he has and will inflict on the USA as a leader on many fronts will be.
Private sector job reports for September show:
ADP: 42,000 jobs added
Challenger: 54,000 job cuts
Bank of America internal data: Steady wage growth but slow down in hiring and likely increased unemployment rate.
CME Fedwatch tool shows a 46% probability of a rate cut in December. It is updated every 24 hours.
Lots of jaw boning from FOMC members.
Jefferson: we should wait
Waller: A preemptive cut will be in order.
Miran(Trump's buddy): cut, cut cut.
Hassett (Senior Administration Economic Adviser): the labor market is in "quiet time" due to AI efficiency (as the AI trade is softening). Yeah...
Folks, thanks for reading, IF you had made it this far.
Best of luck.
BITCOIN → 100K broken. Consolidation in the short zone...BINANCE:BTCUSDT.P broke through the 100K support level and is consolidating within the local range of 94,150 - 97,280. The decline may continue if the market does not receive support (news or other bullish drivers).
Bitcoin is consolidating below the upward trend line of support and below 100K. The price has entered a zone of panic and sell-off. Before the fall, a “liquidity hunt” is possible - a retest of 97300 - 98900.
The price is coming out of consolidation downwards, the bulls were unable to hold the 100K zone. The lack of a bullish driver and the negative fundamental background are doing their job...
Resistance levels: 97280, 98900, 100700
Support levels: 94150, 91900
Before further decline, the market may test the previously broken support zone relative to the upward lower trend line. Focus on the 97280 - 98990 zone. A false breakout and lack of bullish momentum could form a reversal pattern and trigger a decline to 94150 - 91900.
Best regards, R. Linda!
GBP/CHF 1.0520 Confluence Zone , Fibonacci OverlapGBP/CHF Technical Analysis – 1.0520 Confluence Zone (Fibonacci Overlap, Trend-Aligned Setup)
Market Context
GBP/CHF continues to trade within a well-defined bearish trend. The current market structure suggests additional downside potential, with no meaningful signs of a trend reversal at this stage.
Technical Outlook
1️⃣ The broader trend remains firmly bearish, supported by consistent lower highs and lower lows.
2️⃣ A trend-aligned Fibonacci retracement highlights the 0.5–0.618 retracement band, which overlaps with a key structural level near 1.0520. This alignment forms a high-probability confluence zone, combining both Fibonacci and major swing structure.
3️⃣ This area represents a technically significant region where sellers may re-enter the market if bearish momentum continues.
Trade Expectation / Scenario Planning
Closely observe price behavior as it approaches 1.0520. Any signs of rejection, weakening bullish momentum, or bearish confirmation patterns would strengthen the probability of the downtrend resuming from this zone.
NEO: the market wakes up and hints at a bullish reversalNeoGenomics is breaking out of a mid-term descending wedge while forming a clear trend reversal structure with higher lows and steady support above key Fibonacci retracement levels. The 10.00–10.80 area acts as a consolidation range before a potential continuation of the upward move.
The price has already broken the descending trendline, retested it, and is now holding above the 0.705 Fibonacci zone. EMA 20/50/100 are shifting toward a bullish alignment, confirming renewed buying pressure. Volume is increasing — a classic behavior after a prolonged decline. If the structure holds, the next bullish impulse may form right after breaking the 10.80 resistance.
Fundamentally, NeoGenomics is recovering after a sector-wide selloff in biotech. The company continues to strengthen revenue growth, improve its diagnostics portfolio, and reduce financial pressure — factors that often precede medium-term trend reversals in this sector.
Tactical plan: consider long positions after a confirmed breakout above 10.80. Targets: 15.00 (primary supply zone) and 19.20 as an extended target at the upper boundary of the previous long-term structure. Invalidation: breakdown below 9.00.
If the bullish impulse confirms, the move to 15 and beyond may unfold much faster than the market currently expects.
Fundamental Market Analysis for November 19, 2025 USDJPYEvent to watch today:
21:00 EET. USD - FOMC Meeting Minutes
USDJPY:
Risk-off conditions have revived interest in the yen: amid equity weakness and uncertainty around the timing of U.S. data releases, market participants are trimming dollar long positions versus JPY.
Japan-related signals add to the picture: the long end of the JGB curve is edging higher, bringing attention to inflation persistence and authorities’ readiness to react to excessive FX volatility. Cautious remarks from the finance ministry keep markets from setting fresh USD/JPY highs.
If headlines maintain a wary tone and expectations for a December Fed rate cut persist, the pair can retreat below 155 on safe-haven demand and the threat of verbal intervention.
Trade recommendation: SELL 155.500, SL 156.500, TP 154.500
GoldGOLD
- Gold currently bank in range between 4050 & 4100. Not touching price in this range.
- Overall Sells bias remains.
- Waiting for deeper pullbacks to 4115 - 4150's and signs of resistance at supply zone before taking any sell trades.
- Not much in the econ calendar also. Just Fed Miran & Barkin. But we also have Meeting Minutes at 6am which we need to keep an eye out for on any future guidance.
Gold Price Outlook – Trade Setup (XAU/USD)📊 Technical Structure
OANDA:XAUUSD Gold (XAU/USD) is trading around $4,070–4,075, stuck in a short-term range between a capped Resistance Zone at $4,079–4,089 and a Support Zone at $4,034–4,045.
Price has repeatedly failed to close above the $4,080 area, forming a series of lower intraday highs against that resistance band. At the same time, buyers are defending the $4,044 area, but bounces are getting shallower, hinting at fading upside momentum.
As long as price stays below $4,079–4,089, the intraday structure favours a sell-the-rally setup back toward support. A clean break and close above $4,092–4,100 would invalidate the bearish bias and signal that bulls are regaining control.
🎯 Trade Setup
Idea: Sell near resistance, targeting a move back into the support zone.
Direction: Short (sell)
Entry: $4,079 – $4,089 (retest of resistance zone)
Stop Loss: $4,093 (above recent swing highs / resistance band)
Take Profit 1: $4,045
Take Profit 2: $4,035
Risk–Reward Ratio: 1 : 3.48
Bias: Intraday bearish below $4,079–4,089.
A sustained move above $4,100 would invalidate this setup and shift focus back to the topside.
🌐 Macro Background
Gold has bounced back above $4,050, trading near $4,070 as risk-off sentiment returns ahead of the long-delayed batch of US economic data. FXStreet notes that “Gold price attracts some buyers to around $4,070, snapping the three-day losing streak… as traders brace for the long-awaited return of US economic data.”【FXStreet】
Key macro drivers:
Delayed NFP & Data Uncertainty:
The September and October NFP reports were postponed during the US government shutdown. September NFP is now due Thursday, with markets looking for around 50,000 jobs and unemployment at 4.3%. A weaker-than-expected print would likely pressure the USD and support gold, while a stronger report could reinforce the recent dollar rebound and weigh on XAU/USD.
Fed Signalling Caution, Not Panic:
Fed Vice Chair Philip Jefferson said the Fed should proceed “slowly” with further rate reductions.
Atlanta Fed President Bostic and Kansas City Fed President Schmid flagged persistent inflation risks and signalled comfort with holding rates steady.
Their tone has tempered expectations of a December cut.
Market Pricing:
According to CME FedWatch, markets now price roughly a 46.6% chance of a 25 bps cut in December, down from more than 60% a week earlier, reflecting less dovish expectations.
Overall, macro factors are mixed: risk-off flows and data uncertainty lend support to gold, but hawkish Fed commentary and reduced cut odds cap the upside. Against a well-defined technical resistance zone, this combination supports a short-term bearish, sell-rally stance on the intraday chart.
🔑 Key Technical Levels
Resistance Zone: $4,079 – $4,089
Support Zone: $4,034 – $4,045
📌 Trade Summary
XAU/USD is capped beneath $4,079–4,089 while support is clustered around $4,034–4,045. With Fed officials sounding cautious rather than aggressively dovish and December cut odds drifting lower, rallies into resistance look vulnerable.
The preferred approach is to sell into strength near $4,079–4,089 with stop loss around $4,092, targeting a drop back toward $4,045–4,035 ahead of Thursday’s NFP release. A daily close above $4,100 would invalidate the intraday bearish view.
⚠️ Disclaimer
This analysis is for reference only and does not constitute trading advice. Trading involves significant risk, and proper risk management is essential.
Gold price analysis November 18XAUUSD continues to be under downward pressure as the sellers have a clear advantage, pulling the price down to the support zone of 3933. The buyers' efforts to hold the price at the trendline are quite weak, indicating that this support structure is at risk of being penetrated and the market may extend its decline to lower areas.
At this point, observing the price reaction at important support levels on the chart is the key factor to find a safe entry point.
Preferred trading scenario:
BUY when the market refuses to fall deeply and there is a clear reversal signal at the zone of 3973 - 3933.
Target: immediate target towards 4104, further extension to 4203.
Risk note: the uptrend will be invalidated if the H4 candle closes below 3933.
ES (SPX, SPY) Analyses, Key Zones, Setups for Wed (Nov 19th)Market Analysis: A Shift in Momentum for ES
In today's market, the daily chart for the E-mini S&P 500 (ES) reveals a notable shift in momentum, characterized by a sequence of price action that signals a potential downtrend. Previously, we observed a high, followed by a lower high, and today's movement has decisively broken through the last remaining support at the higher-low shelf. This change comes after a rejection from the recent lower-high zone, situated just below the 6,900 mark, followed by a retreat through the crucial 6,700 threshold. What initially appeared to be a bullish uptick is now consolidating into a corrective downswing.
Today's significant drop marks the continuation of this emerging downward trajectory. Prices breached intraday support around 6,675 to 6,700, slid past the prior higher-low region near 6,635, and ultimately settled atop the initial daily demand zone. Notably, the selling volume during this decline expanded compared to previous sessions, underscoring that this movement reflects genuine market participation rather than mere fluctuations.
While the longer-term outlook remains bullish, reflected in the weekly trend, the daily and four-hour charts currently indicate a pronounced short-term downtrend. Key indicators include the formation of a lower high, the breach of the previous higher-low, and a liquidity run to the downside toward the extension cluster. As we move forward, this developing bearish scenario suggests potential for further declines in the coming sessions, though we are positioned within local demand territory, indicating that bounces and two-directional trading are likely in the near term.
Key Resistance Zones
Resistance 1: 6,637
This level represents today’s late-session swing high on the 30-minute chart, denoted as the S-session high (S.H 6,637). It serves as the initial resistance point above the current market price.
Resistance 2: 6,679.75 – 6,687.50
A cluster of highs, with NYAM.H marked at 6,679.75, LO.H at 6,685.75, and NYPM.H at 6,687.50, forms a critical intraday supply pocket. This region represents the primary A++ short zone should the price experience a bounce.
Resistance 3: 6,700 – 6,720
Above the NY session high band, the 4-hour chart highlights a previously broken support shelf and local supply just below 6,720. Any movement back into this area would likely be corrective within the ongoing downswing unless the E-mini S&P can close and hold a daily candle above this range.
Higher-Timeframe Cap:
Any price action remaining below the recent daily lower-high zone—situated near the last significant LH before the drop—maintains a bearish bias for the larger swing. A definitive daily close above this lower-high would be necessary to negate the current short-term downtrend.
---
Key Support Zones
Support 1: 6,627.50 and 6,614.75
The AS.L level is printed at 6,627.50, with the NL.L around 6,614.75 on the 30-minute chart. Together, these levels form the initial local support shelf just beneath the current price.
Support 2: 6,606.50 – 6,603.25
Marked by NYPM.L at 6,606.50 and NYAM.L at 6,603.25, this band serves as the next area of resting liquidity from today’s trading sessions. A clean break and sustained move below this range could pave the way for the Fibonacci targets below.
Support 3 (Major Fibonacci Cluster): 6,541.50 – 6,509.00
On the 1-hour chart, the 1.272 Fibonacci level is found at 6,541.50, while the 4-hour chart places it at 6,509.00. The daily chart marks the 1.272 at 6,521.25, creating a significant demand box from approximately 6,541 down to 6,509, with 6,521 serving as a mid-pivot. This is the pivotal "bounce or break" zone.
Support 4 (Deeper Extension Pocket): 6,501.75 – 6,458.00
The 1-hour chart identifies the 1.618 Fibonacci extension at 6,501.75 and the 2.0 extension at 6,458.00. The 4-hour chart aligns the 1.618 at 6,429.25 and the 2.0 at 6,341.50, with the daily chart placing the 1.618 at 6,418.00 and the 2.0 around 6,304.00. The initial focus for tomorrow is the 6,502–6,458 region. Should the 6,541–6,509 band fail, this area becomes a strong magnet where a more pronounced short-covering bounce is likely.
The definitive structural line on the downside is the cumulative daily 1.618–2.0 cluster, ranging from approximately 6,418 down to 6,304. A decline to this range could signify a major correction leg rather than a mere shallow pullback.
A++ SETUP 1 — REJECTION SHORT FROM NY HIGH BAND
Trigger:
15m: candle wicks into 6,680–6,688 and closes back below about 6,675.
5m/1m: a failed attempt to push higher (lower high) after that rejection.
Entry:
Aggressive: enter short 6,678–6,682 after the 15m rejection close and 1m fails to make new highs.
Conservative: limit sell in 6,680–6,685 on a controlled retest from below.
Stop (hard invalidation):
Around 6,698.00 above the band and intraday highs (about 16–20 points of risk if filled 6,678–6,682).
Targets:
TP1: 6,637.00 (session swing high). From 6,680 entry with 6,698 stop ≈ 2.3R.
TP2: 6,606.50 – 6,603.25 (NYPM.L / NYAM.L shelf), ≈ 4R from 6,680 entry.
TP3: 6,541.50 – 6,521.25 (top of fib demand cluster), campaign-style extension.
A++ SETUP 2 — EXHAUSTION LONG FROM FIB CLUSTER DEMAND
Trigger:
15m: price trades below 6,530, tags 6,521–6,509, then closes back above about 6,530 (wick through, body back up).
5m/1m: a higher low forms above roughly 6,520 after that reclaim; sellers fail to push back below the cluster.
Entry:
Aggressive: 6,525–6,535 on the first higher low on 1m/5m after the 15m reclaim of 6,530.
Conservative: limit buy near 6,525 on a controlled retest into the top of the cluster after the first reaction.
Stop (hard invalidation):
Around 6,497.00 under the bottom of the cluster and recent swing low (≈ 30–38 points of risk if entered 6,525–6,535).
Targets:
TP1: 6,595–6,600 (broken structure and local VWAP zone). From 6,530 entry with 6,497 stop ≈ 2R.
TP2: 6,637.00 (S-session high and first major resistance).
TP3: 6,679.75 – 6,687.50 (NYAM.H / LO.H / NYPM.H band), where a bounce can turn into a full squeeze.
Upcoming Economic Indicators
For tomorrow's trading session (Wednesday, U.S. time), traders should keep an eye on several key economic releases:
- At 8:30 AM ET, the U.S. will release Housing Starts and Building Permits for October, along with import/export price indices. These figures are vital for gauging growth, especially after a series of subdued permits and erratic starts.
- At 10:30 AM ET, the EIA Weekly Petroleum Status Report, alongside crude inventory data, is expected to influence energy markets and broader risk sentiment.
- Later in the afternoon, markets will be attentive to FOMC minutes and remarks from New York Fed President John Williams, both of which could impact rate-cut expectations based on the overall tone relative to recent communications.
Good luck !!!
Ethereum | Redistribution in the MakingEthereum is carving out what appears to be a redistribution structure, but the context hints we may still need one more push upward, possibly a Last Point of Supply (LPSY) or even a UTAD (Upthrust After Distribution), before the markdown phase resumes.
Wyckoff Structure Overview:
Selling Climax (SC) and Automatic Reaction (AR) defined the lower boundary.
Secondary Test (ST) confirmed demand depletion.
Upthrust (UT) established resistance and began drawing a trendline of liquidity across the highs.
The recent Sign of Weakness (SOW) confirms heavy supply entering, but price action is extended and could retrace to relieve pressure.
The PSY zone between $3,580–$3,740 remains untested, aligning with both a liquidity pool and potential LPSY/UTAD territory. That’s where we’ll likely see whether this range completes redistribution or transforms into an even broader distribution with a deceptive final trap.
Volume and CVD Analysis
During the SOW, volume spiked — strong selling pressure confirmed. Yet CVD is diverging, showing aggressive sellers losing momentum while absorption quietly builds.
If we see a sharp rebound on weak delta, that will likely be smart money offloading into strength — the signature of an LPSY or UTAD.
The Lunar Influence
We’re in Lunar Day 23, during the Last Quarter Moon in Virgo — a cosmic rhythm often tied to misleading signals, short-lived reversals, and exaggerated reactions.
This phase tends to produce fakeouts that look like Signs of Strength or Signs of Weakness, but are actually exhaustion moves or liquidity grabs before the real continuation.
In Wyckoff terms, Lunar Day 23 energy often shows Phase C deception, which could be a UTAD disguised as a breakout or a terminal shakeout before markdown.
What to Watch Next
Rebound on declining volume → potential LPSY/UTAD forming.
Failed rally into the PSY zone with increased spread down-bars → confirmation of redistribution continuing.
Strong bullish delta with no follow-through → likely fake strength under Lunar Day 23 conditions.
BTC Sector 100150.0 — The Gates That Have Not Yet Opened🏷 BTC
🏷 19.11.2025
🏷 Capital Sector. Price Slice. System of Intelligent Anticipation. Capital Mapping — before instrument touch, this price slice is the planned action of major players.
🏷 Sector 100150.0 — The Gates That Have Not Yet Opened
🏷 The price has not touched the level — yet the market already stands at the threshold.
This is not resistance.
This is a sealed trajectory.
Those who see only candles — hear no whisper of liquidity.
Those who wait for signals — feel no pull of structure.
100150.0 is not a level.
It is the point where capital reconfigures its consciousness.
Some will buy.
Some will sell.
But only The Architect knows:
This is not the end of the move.
It is the beginning of its hidden cycle.
🏷 — The Architect, Capital Sector
🏷The language of markets is written in silence.
You do not predict it.
You recognize it — when it has already begun.
XAUUSD trading Plan- 18th Nov 2025Quick Technical Read
• Price bounced from 3988 and is now forming a corrective pullback upward.
• MACD histogram flipped positive, showing short-term bullish momentum.
• But the main trend is still down, and strong resistance sits at 4068–4080 and especially 4140.
• Current zone (4055–4060) is a decision point.
So we treat this as a range inside a downtrend → buy low, sell high with tight risk.
BUY (Short-term rebound)
4038 – 4046
Stop-Loss:
4024
Take-Profit:
• TP1: 4065
• TP2: 4080
Reason:
MACD momentum is up, and price is holding above the intraday support around 4035–4040
SELL (Trend continuation)
When volume increases, the downtrend usually resumes.
SELL Entry Zones:
• 4068 – 4075
• Second sell zone if price spikes: 4088 – 4095
Stop-Loss:
4108
Take-Profit:
• TP1: 4038
• TP2: 4015
• TP3: 3995 (if market turns aggressively bearish)
Reason:
4068–4080 is strong resistance and aligns with the major downtrend structure.
BTC Sector 85509.64: Capital Before the Tremor🏷 BTC Sector 85509.64: Capital Before the Tremor
🏷 19.11.2025
🏷 Capital Sector. Price Slice. System of Intelligent Anticipation. Capital Mapping — before instrument touch, this price slice is the planned action of major players.
🏷 85509.64 — As of publication, price has not yet reached this level.
🏷 The price has not yet touched the level — yet the structure already knows the path.
In the silence between orders, in the weight of unfilled volumes — the whisper of capital.
This slice is not a forecast. It is the market’s mind, frozen in numbers before the moment of truth.
🏷 Sector 85509.64 is active.
Touch — not if, but when.
Capital moves in silence.
The System sees ahead.
🏷 The light at the end of the tunnel — where others see only darkness.
🏷 — The Architect, Capital Sector
Sellers profit-taking or new buyers entering the marketThe shadow at the low of the daily price structure for Tuesday in the S&P 500 implies two possibilities sellers may have pushed the market low enough that some people are taking profits a second possibility is the market's gotten cheap enough that new buyers are establishing positions. The price action on Wednesday may give us answers depending on follow through from buyers in the market.
SOLV about to 10x–100x from here | Smart Money quietly loading tThis is NOT Solana ( CRYPTOCAP:SOL ) – this is NYSE:SOLV (Solana VM chain) sitting at the EXACT bottom that printed the +28,000% pump last cycle.
What you’re seeing right now:
- Yearly support held perfectly for 18 months
- Final deviation + reclaim (smart money’s favorite setup)
- 4 layered buy zones I’m filling aggressively: 0.01503 → 0.01526 → 0.01552 → 0.01623
- Volume drying up = calm before the most violent leg up
Last time this level was touched → price went from $0.008 → $2.35 in 4 months.
If you miss this dip, you’ll be buying my bags at $0.50–$1.50 screaming “why didn’t I listen”.
This is the literal “before” picture everyone screenshots in 3 months saying “I was here”.
Not financial advice – just showing you where the rocket fuel is.
#SOLV #100xGem #LowCapSeason #Crypto #Altseason
Screenshot this chart. Thank me in January.
STRKUSDT - The real STAR!Let me introduce you to the new rising star that’s about to steal the spotlight: STRK.
The coin has been pumping like crazy for the past few days, but once you zoom out and check the chart, you’ll see that this is just the beginning — a clean breakout from a 258-day accumulation range.
Not only that, but it also broke the long-term descending trendline (from day one of the project) and successfully retested it.
I’m not exaggerating when I say the minimum target lies around the 0.618 Fibonacci level,
which is roughly a 3× move from the current price.
Best Regards:
Ceciliones🎯






















